| Year |
Citation |
Score |
| 2015 |
Sherman S, Rathnayake N, Mdzinarishvili T. Invariant Characteristics of Carcinogenesis. Plos One. 10: e0140405. PMID 26465159 DOI: 10.1371/Journal.Pone.0140405 |
0.331 |
|
| 2014 |
Mdzinarishvili T, Sherman A, Shats O, Sherman S. Web tool for estimating the cancer hazard rates in aging. Cancer Informatics. 13: 197-205. PMID 25788828 DOI: 10.4137/Cin.S19777 |
0.331 |
|
| 2014 |
Mdzinarishvili T, Sherman S. Heuristic modeling of carcinogenesis for the population with dichotomous susceptibility to cancer: a pancreatic cancer example. Plos One. 9: e100087. PMID 24932779 DOI: 10.1371/Journal.Pone.0100087 |
0.32 |
|
| 2014 |
Cheng P, Kumar V, Liu H, Youn JI, Fishman M, Sherman S, Gabrilovich D. Effects of notch signaling on regulation of myeloid cell differentiation in cancer. Cancer Research. 74: 141-52. PMID 24220241 DOI: 10.1158/0008-5472.Can-13-1686 |
0.302 |
|
| 2013 |
Mdzinarishvili T, Sherman S. Basic equations and computing procedures for frailty modeling of carcinogenesis: application to pancreatic cancer data. Cancer Informatics. 12: 67-81. PMID 23471174 DOI: 10.4137/Cin.S8063 |
0.311 |
|
| 2012 |
Sherman S, Gleason M, Mdzinarishvili T, Sherman A, Shats O, Are C, Sasson A, Haynatzki G. Abstract 5502: Prognostic tools for pancreatic cancer survival Cancer Research. 72: 5502-5502. DOI: 10.1158/1538-7445.Am2012-5502 |
0.307 |
|
| 2011 |
Sherman S, Shats O, Fleissner E, Bascom G, Yiee K, Copur M, Crow K, Rooney J, Mateen Z, Ketcham MA, Feng J, Sherman A, Gleason M, Kinarsky L, Silva-Lopez E, et al. Multicenter breast cancer collaborative registry. Cancer Informatics. 10: 217-26. PMID 21918596 DOI: 10.4137/Cin.S7845 |
0.302 |
|
| 2011 |
Sherman S, Shats O, Ketcham MA, Anderson MA, Whitcomb DC, Lynch HT, Ghiorzo P, Rubinstein WS, Sasson AR, Grizzle WE, Haynatzki G, Feng J, Sherman A, Kinarsky L, Brand RE. PCCR: Pancreatic Cancer Collaborative Registry. Cancer Informatics. 10: 83-91. PMID 21552494 DOI: 10.4137/Cin.S6919 |
0.315 |
|
| 2010 |
Mdzinarishvili T, Sherman S. Weibull-like Model of Cancer Development in Aging. Cancer Informatics. 9: 179-88. PMID 20838610 DOI: 10.4137/Cin.S5460 |
0.342 |
|
| 2009 |
Mdzinarishvili T, Gleason MX, Kinarsky L, Sherman S. A Generalized Beta model for the age distribution of cancers: application to pancreatic and kidney cancer. Cancer Informatics. 7: 183-97. PMID 19718452 DOI: 10.4137/Cin.S3050 |
0.33 |
|
| 2009 |
Mdzinarishvili T, Gleason MX, Sherman S. Comment re: Cancer incidence falls for oldest. Cancer Research. 69: 379; author reply 37. PMID 19118024 DOI: 10.1158/0008-5472.Can-08-2973 |
0.309 |
|
| 2009 |
Ninkovic T, Kinarsky L, Engelmann K, Pisarev V, Sherman S, Finn OJ, Hanisch FG. Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes. Molecular Immunology. 47: 131-40. PMID 19007994 DOI: 10.1016/J.Molimm.2008.09.032 |
0.303 |
|
| 2007 |
Nefedova Y, Fishman M, Sherman S, Wang X, Beg AA, Gabrilovich DI. Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. Cancer Research. 67: 11021-8. PMID 18006848 DOI: 10.1158/0008-5472.Can-07-2593 |
0.31 |
|
| 2007 |
Nagaraj S, Pisarev V, Kinarsky L, Sherman S, Muro-Cacho C, Altieri DC, Gabrilovich DI. Dendritic cell-based full-length survivin vaccine in treatment of experimental tumors. Journal of Immunotherapy (Hagerstown, Md. : 1997). 30: 169-79. PMID 17471164 DOI: 10.1097/01.Cji.0000211329.83890.Ba |
0.31 |
|
| 2005 |
von Mensdorff-Pouilly S, Kinarsky L, Engelmann K, Baldus SE, Verheijen RH, Hollingsworth MA, Pisarev V, Sherman S, Hanisch FG. Sequence-variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differential B lymphocyte responses. Glycobiology. 15: 735-46. PMID 15814824 DOI: 10.1093/Glycob/Cwi058 |
0.318 |
|
| 2005 |
Pisarev VM, Kinarsky L, Caffrey T, Hanisch FG, Sanderson S, Hollingsworth MA, Sherman S. T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1. International Immunopharmacology. 5: 315-30. PMID 15652762 DOI: 10.1016/J.Intimp.2004.10.004 |
0.312 |
|
| Show low-probability matches. |